0
0
0
Prioritizing Medical Countermeasures for National Security Act of 2023
12/15/2023, 4:07 PM
Summary of Bill S 1122
Bill 118 s 1122, also known as the Prioritizing Medical Countermeasures for National Security Act of 2023, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to prioritize the development and distribution of medical countermeasures in order to enhance national security.
The bill outlines several key provisions, including the establishment of a National Medical Countermeasure Prioritization Task Force. This task force would be responsible for identifying and prioritizing medical countermeasures that are critical to national security. Additionally, the bill calls for the creation of a National Medical Countermeasure Stockpile, which would ensure that essential medical supplies are readily available in the event of a national emergency.
Furthermore, the bill emphasizes the importance of collaboration between government agencies, private sector partners, and international organizations in order to effectively respond to public health threats. It also highlights the need for increased funding and resources to support the development and distribution of medical countermeasures. Overall, Bill 118 s 1122 aims to strengthen the nation's ability to respond to biological threats and other public health emergencies by prioritizing the development and distribution of medical countermeasures. If passed, this legislation could have a significant impact on national security and public health preparedness.
The bill outlines several key provisions, including the establishment of a National Medical Countermeasure Prioritization Task Force. This task force would be responsible for identifying and prioritizing medical countermeasures that are critical to national security. Additionally, the bill calls for the creation of a National Medical Countermeasure Stockpile, which would ensure that essential medical supplies are readily available in the event of a national emergency.
Furthermore, the bill emphasizes the importance of collaboration between government agencies, private sector partners, and international organizations in order to effectively respond to public health threats. It also highlights the need for increased funding and resources to support the development and distribution of medical countermeasures. Overall, Bill 118 s 1122 aims to strengthen the nation's ability to respond to biological threats and other public health emergencies by prioritizing the development and distribution of medical countermeasures. If passed, this legislation could have a significant impact on national security and public health preparedness.
Congressional Summary of S 1122
Prioritizing Medical Countermeasures for National Security Act of 2023
This bill requires the Administration for Strategic Preparedness and Response (ASPR) to establish a list of categories of drugs that may be necessary to address a public health emergency or threat to the Armed Forces in order to facilitate the development of such drugs.
Specifically, ASPR must list categories and classes of drugs that may be necessary to prevent or treat diseases or conditions that are caused by chemical, biological, radiological, or nuclear agents and that have the potential to cause a public health emergency that threatens national security, or that may pose a threat to the Armed Forces. ASPR must share the list with interested parties to incentivize development and speed review of relevant drug applications.
The Government Accountability Office must report on the bill's effectiveness in encouraging the development of necessary medical countermeasures.
Read the Full Bill
Current Status of Bill S 1122
Bill S 1122 is currently in the status of Bill Introduced since March 30, 2023. Bill S 1122 was introduced during Congress 118 and was introduced to the Senate on March 30, 2023. Bill S 1122's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 30, 2023
Bipartisan Support of Bill S 1122
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
4Democrat Cosponsors
0Republican Cosponsors
4Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 1122
Primary Policy Focus
HealthAlternate Title(s) of Bill S 1122
Prioritizing Medical Countermeasures for National Security Act of 2023
Prioritizing Medical Countermeasures for National Security Act of 2023
A bill to improve the program to provide for priority review of human drug applications to encourage treatment for agents that present national security threats.
Comments
Sponsors and Cosponsors of S 1122
Latest Bills
Protecting America’s Orchardists and Nursery Tree Growers Act
Bill HR 8251April 15, 2026
Healthy Watersheds, Healthy Communities Act of 2026
Bill S 4234April 15, 2026
Consumer Data Privacy and Security Act of 2026
Bill S 4211April 15, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Bulletin 2015-07 re: in-person collection of consumer debt".
Bill SJRES 162April 15, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-05: Debt Collection and Consumer Reporting Practices Involving Invalid Nursing Home Debts".
Bill SJRES 159April 15, 2026
A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress.
Bill SJRES 163April 15, 2026
A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress.
Bill SJRES 161April 15, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Compliance Bulletin 2016-03: Detecting and Preventing Consumer Harm From Production Incentives".
Bill SJRES 170April 15, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-06: Unanticipated Overdraft Fee Assessment Practices".
Bill SJRES 169April 15, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2023-01: Unlawful Negative Option Marketing Practices".
Bill SJRES 160April 15, 2026